We are live on ! Find out more
JFL

Jarislowsky, Fraser Ltd Portfolio holdings

AUM $18.2B
1-Year Est. Return 22.04%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+22.04%
3 Year Est. Return
+92.62%
5 Year Est. Return
+122.31%
10 Year Est. Return
+241.46%
AUM
$14.7B
AUM Growth
-$302M
Cap. Flow
+$61.8M
Cap. Flow %
0.42%
Top 10 Hldgs %
47.55%
Holding
147
New
1
Increased
42
Reduced
93
Closed
3

Top Buys

Rank Stock Value
1
GIL icon
Gildan
GIL
+$134M
2
STN icon
Stantec
STN
+$84.5M
3
IMS
IMS HEALTH HLDGS INC COM STK (DE)
IMS
+$43.5M
4
OTEX icon
Open Text
OTEX
+$37.1M
5
TJX icon
TJX Companies
TJX
+$20.4M

Top Sells

Rank Stock Value
1
BNS icon
Scotiabank
BNS
+$30.3M
2
TD icon
Toronto Dominion Bank
TD
+$27.9M
3
RY icon
Royal Bank of Canada
RY
+$24.8M
4
AGN
Allergan plc
AGN
+$19.2M
5
ENB icon
Enbridge
ENB
+$16.4M

Sector Composition

Rank Sector Weight
1 Financials 31.14%
2 Energy 23.04%
3 Industrials 13.61%
4 Technology 9.6%
5 Healthcare 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLF icon
101
Sun Life Financial
SLF
$43.8B
$10.1M 0.07%
303,375
-1,255
-0.4% -$41.4K
MA icon
102
Mastercard
MA
$521B
$9.83M 0.07%
105,138
+2,123
+2% +$195K
TU icon
103
Telus
TU
$15.2B
$9.36M 0.06%
543,514
-75,156
-12% -$1.29M
OVV icon
104
Ovintiv
OVV
$17.9B
$7.85M 0.05%
142,389
-16,338
-10% -$1.04M
NVO
105
Novo Nordisk
NVO
$202B
$7.17M 0.05%
261,980
-3,050
-1% -$85.7K
LUX
106
DELISTED
Luxottica Group
LUX
$6.77M 0.05%
101,849
+1,633
+2% +$108K
NVS icon
107
Novartis
NVS
$292B
$6.44M 0.04%
73,135
+949
+1% +$87.1K
ZTS icon
108
Zoetis
ZTS
$32B
$6.25M 0.04%
129,567
+22,281
+21% +$1.06M
MRK icon
109
Merck
MRK
$366B
$5.51M 0.04%
101,430
-3,129
-3% -$175K
HIG icon
110
Hartford Financial Services
HIG
$37.5B
$5.32M 0.04%
127,908
-4,700
-4% -$196K
ING icon
111
ING
ING
$101B
$3.67M 0.03%
221,553
+2,188
+1% +$34.8K
SAN icon
112
Banco Santander
SAN
$213B
$3.62M 0.02%
543,551
-4,822
-0.9% -$33.6K
MUFG icon
113
Mitsubishi UFJ Financial
MUFG
$258B
$3.55M 0.02%
492,035
-2,461
-0.5% -$17.5K
ABB
114
DELISTED
ABB Ltd
ABB
$3.48M 0.02%
166,868
+970
+0.6% +$21.3K
TGT icon
115
Target
TGT
$74.1B
$3.29M 0.02%
40,276
-11,515
-22% -$932K
DGX icon
116
Quest Diagnostics
DGX
$26.8B
$2.75M 0.02%
37,982
-3,040
-7% -$224K
HAL icon
117
Halliburton
HAL
$30.1B
$2.47M 0.02%
57,338
-1,732
-3% -$79.8K
CSCO icon
118
Cisco
CSCO
$433B
$2.42M 0.02%
88,127
-15,050
-15% -$432K
CM icon
119
Canadian Imperial Bank of Commerce
CM
$104B
$2.21M 0.02%
59,904
+14
+0% +$540
UN
120
DELISTED
Unilever NV New York Registry Shares
UN
$1.78M 0.01%
42,641
-200
-0.5% -$8.63K
COF icon
121
Capital One
COF
$132B
$1.78M 0.01%
+20,257
New +$1.7M
MDT icon
122
Medtronic
MDT
$117B
$1.76M 0.01%
23,714
-5,350
-18% -$409K
AAPL icon
123
Apple
AAPL
$4.67T
$1.61M 0.01%
51,276
-800
-2% -$25.6K
FHN icon
124
First Horizon
FHN
$11.7B
$1.57M 0.01%
100,279
WMT icon
125
Walmart Inc
WMT
$820B
$1.54M 0.01%
65,235
+1,512
+2% +$38.6K

Similar funds

Jarislowsky, Fraser Ltd's Q2 2015 Portfolio in Review

As of Q2 2015, Jarislowsky, Fraser Ltd held 147 positions worth $14.7B, down 2% from $15B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 2.7%. Jarislowsky, Fraser Ltd opened 1 new position and exited 3, leaving the 147-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Energy and Industrials.

  • Jarislowsky, Fraser Ltd's largest Q2 2015 buy was Capital One: 20,257 shares worth $1.78M.
  • Jarislowsky, Fraser Ltd added most to Gildan in Q2 2015, an estimated $134M increase.
  • Jarislowsky, Fraser Ltd's biggest Q2 2015 reduction was Scotiabank, cutting an estimated $30.3M.
  • Jarislowsky, Fraser Ltd fully exited Allergan plc in Q2 2015, selling an estimated $19.2M.
  • Jarislowsky, Fraser Ltd's ten largest holdings make up 48% of its $14.7B portfolio in Q2 2015.
  • Jarislowsky, Fraser Ltd opened 1 new position and closed 3 in Q2 2015.
  • Jarislowsky, Fraser Ltd's portfolio value fell 2% quarter-over-quarter to $14.7B.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q2 2015, filed 11 Aug 2015.